nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2E1—Fingolimod—multiple sclerosis	0.285	0.307	CbGbCtD
Paramethadione—CYP2E1—Mitoxantrone—multiple sclerosis	0.134	0.144	CbGbCtD
Paramethadione—CYP3A4—Fingolimod—multiple sclerosis	0.0863	0.0931	CbGbCtD
Paramethadione—CYP2E1—Dexamethasone—multiple sclerosis	0.0694	0.0748	CbGbCtD
Paramethadione—CYP3A4—Methylprednisolone—multiple sclerosis	0.0556	0.06	CbGbCtD
Paramethadione—CYP2C8—Dexamethasone—multiple sclerosis	0.0519	0.0559	CbGbCtD
Paramethadione—CYP3A4—Triamcinolone—multiple sclerosis	0.0422	0.0454	CbGbCtD
Paramethadione—CYP3A4—Mitoxantrone—multiple sclerosis	0.0406	0.0437	CbGbCtD
Paramethadione—CYP2C9—Dexamethasone—multiple sclerosis	0.0362	0.039	CbGbCtD
Paramethadione—CYP3A4—Betamethasone—multiple sclerosis	0.0362	0.039	CbGbCtD
Paramethadione—CYP3A4—Prednisolone—multiple sclerosis	0.0357	0.0385	CbGbCtD
Paramethadione—CYP3A4—Prednisone—multiple sclerosis	0.0337	0.0363	CbGbCtD
Paramethadione—CYP3A4—Dexamethasone—multiple sclerosis	0.021	0.0227	CbGbCtD
Paramethadione—CACNA1I—NCAM1 interactions—PRNP—multiple sclerosis	0.00411	0.0568	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM1 interactions—PRNP—multiple sclerosis	0.00303	0.0419	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM1 interactions—PRNP—multiple sclerosis	0.00293	0.0406	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00241	0.0334	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—CD24—multiple sclerosis	0.0021	0.0291	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00178	0.0246	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00172	0.0239	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—CD24—multiple sclerosis	0.00155	0.0214	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—CD24—multiple sclerosis	0.0015	0.0207	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—CD24—multiple sclerosis	0.0015	0.0207	CbGpPWpGaD
Paramethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0014	0.0194	CbGpPWpGaD
Paramethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0014	0.0194	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—CD24—multiple sclerosis	0.0011	0.0153	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—CD24—multiple sclerosis	0.00107	0.0148	CbGpPWpGaD
Paramethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000987	0.0137	CbGpPWpGaD
Paramethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000987	0.0137	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000891	0.0123	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000891	0.0123	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000879	0.0122	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000879	0.0122	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.00084	0.0116	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00077	0.0107	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00077	0.0107	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00076	0.0105	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00076	0.0105	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000722	0.00999	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000722	0.00999	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—PRNP—multiple sclerosis	0.000693	0.00958	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000651	0.00901	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000651	0.00901	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000627	0.00867	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000627	0.00867	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000624	0.00864	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000624	0.00864	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000619	0.00857	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000618	0.00856	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000618	0.00856	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.000605	0.00837	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.0006	0.0083	CbGpPWpGaD
Paramethadione—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000576	0.00798	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—PTPRC—multiple sclerosis	0.000539	0.00745	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000535	0.0074	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.00053	0.00734	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—PRNP—multiple sclerosis	0.000511	0.00706	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000508	0.00703	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000508	0.00703	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—PRNP—multiple sclerosis	0.000494	0.00684	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—PRNP—multiple sclerosis	0.000494	0.00684	CbGpPWpGaD
Paramethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000459	0.00635	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	0.000428	0.00593	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000413	0.00572	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000413	0.00572	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000411	0.00569	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000408	0.00564	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000408	0.00564	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—PTPRC—multiple sclerosis	0.000397	0.00549	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000394	0.00546	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000392	0.00542	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—PTPRC—multiple sclerosis	0.000385	0.00532	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—PTPRC—multiple sclerosis	0.000384	0.00532	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000384	0.00531	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000384	0.00531	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000382	0.00528	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000378	0.00524	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000378	0.00524	CbGpPWpGaD
Paramethadione—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000371	0.00513	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—PRNP—multiple sclerosis	0.000364	0.00504	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	0.000354	0.0049	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—PRNP—multiple sclerosis	0.000353	0.00488	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000335	0.00464	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000335	0.00464	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000332	0.00459	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000332	0.00459	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000327	0.00453	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000327	0.00453	CbGpPWpGaD
Paramethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000323	0.00447	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000306	0.00423	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000303	0.00419	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.0003	0.00415	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000293	0.00406	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—PTPRC—multiple sclerosis	0.000283	0.00392	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—PTPRC—multiple sclerosis	0.000274	0.0038	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.00027	0.00373	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.00027	0.00373	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000266	0.00368	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000266	0.00368	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—TYK2—multiple sclerosis	0.000241	0.00333	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000213	0.00295	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.0002	0.00277	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MMP9—multiple sclerosis	0.00019	0.00263	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000178	0.00246	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000178	0.00246	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—TYK2—multiple sclerosis	0.000178	0.00246	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000176	0.00243	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000176	0.00243	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000173	0.0024	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—TYK2—multiple sclerosis	0.000172	0.00238	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TYK2—multiple sclerosis	0.000172	0.00238	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000162	0.00225	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MAPK1—multiple sclerosis	0.000153	0.00212	CbGpPWpGaD
Paramethadione—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000148	0.00205	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000141	0.00195	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00014	0.00194	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MMP9—multiple sclerosis	0.00014	0.00194	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MMP9—multiple sclerosis	0.000136	0.00188	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MMP9—multiple sclerosis	0.000135	0.00187	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000127	0.00176	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000127	0.00176	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TYK2—multiple sclerosis	0.000127	0.00175	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TYK2—multiple sclerosis	0.000123	0.0017	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—STAT3—multiple sclerosis	0.00012	0.00167	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6—multiple sclerosis	0.000118	0.00163	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000114	0.00158	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MAPK1—multiple sclerosis	0.000113	0.00156	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TGFB1—multiple sclerosis	0.000112	0.00154	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MAPK1—multiple sclerosis	0.00011	0.00152	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MAPK1—multiple sclerosis	0.000109	0.00151	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TNF—multiple sclerosis	0.000104	0.00144	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000104	0.00143	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000104	0.00143	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MMP9—multiple sclerosis	9.98e-05	0.00138	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MMP9—multiple sclerosis	9.67e-05	0.00134	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SRM—multiple sclerosis	9.31e-05	0.00129	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.3e-05	0.00129	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—STAT3—multiple sclerosis	8.88e-05	0.00123	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6—multiple sclerosis	8.69e-05	0.0012	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—POMC—multiple sclerosis	8.63e-05	0.00119	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—STAT3—multiple sclerosis	8.6e-05	0.00119	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6—multiple sclerosis	8.42e-05	0.00116	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6—multiple sclerosis	8.41e-05	0.00116	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TGFB1—multiple sclerosis	8.23e-05	0.00114	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MAPK1—multiple sclerosis	8.07e-05	0.00112	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SRM—multiple sclerosis	8.05e-05	0.00111	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TGFB1—multiple sclerosis	7.97e-05	0.0011	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MAPK1—multiple sclerosis	7.82e-05	0.00108	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TNF—multiple sclerosis	7.68e-05	0.00106	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.54e-05	0.00104	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—POMC—multiple sclerosis	7.46e-05	0.00103	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TNF—multiple sclerosis	7.44e-05	0.00103	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	6.56e-05	0.000908	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	6.56e-05	0.000908	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SRM—multiple sclerosis	6.55e-05	0.000906	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6—multiple sclerosis	6.2e-05	0.000858	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—POMC—multiple sclerosis	6.07e-05	0.00084	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6—multiple sclerosis	6.01e-05	0.000831	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GPC5—multiple sclerosis	6e-05	0.00083	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	5.67e-05	0.000785	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	5.67e-05	0.000785	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.54e-05	0.000767	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GPC5—multiple sclerosis	5.19e-05	0.000718	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—RRM1—multiple sclerosis	4.97e-05	0.000688	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	4.62e-05	0.000639	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	4.62e-05	0.000639	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.51e-05	0.000624	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SRM—multiple sclerosis	4.32e-05	0.000598	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—RRM1—multiple sclerosis	4.3e-05	0.000595	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.22e-05	0.000584	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4e-05	0.000554	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.5e-05	0.000484	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.33e-05	0.000461	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.04e-05	0.000421	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.04e-05	0.000421	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.86e-05	0.000396	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.86e-05	0.000395	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.78e-05	0.000385	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.71e-05	0.000376	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.61e-05	0.000361	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.47e-05	0.000342	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.33e-05	0.000323	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.31e-05	0.000319	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.13e-05	0.000294	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.01e-05	0.000278	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—APOE—multiple sclerosis	1.72e-05	0.000238	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—APOE—multiple sclerosis	1.48e-05	0.000205	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—POMC—multiple sclerosis	1.48e-05	0.000204	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ALB—multiple sclerosis	1.35e-05	0.000186	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.32e-05	0.000183	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—POMC—multiple sclerosis	1.28e-05	0.000177	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—APOE—multiple sclerosis	1.21e-05	0.000167	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ALB—multiple sclerosis	1.16e-05	0.000161	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—POMC—multiple sclerosis	1.04e-05	0.000144	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ALB—multiple sclerosis	9.47e-06	0.000131	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—APOE—multiple sclerosis	7.97e-06	0.00011	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—POMC—multiple sclerosis	6.85e-06	9.47e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ALB—multiple sclerosis	6.24e-06	8.64e-05	CbGpPWpGaD
